期刊文献+

家族性高胆固醇血症治疗进展 被引量:7

原文传递
导出
摘要 家族性高胆固醇血症(FH)是以血浆低密度脂蛋白胆固醇(LDL-C)异常升高、外周组织黄色瘤、动脉粥样硬化(AS)甚至早发冠心病为特征的常染色体显性遗传病。
出处 《中华内科杂志》 CAS CSCD 北大核心 2013年第11期989-991,共3页 Chinese Journal of Internal Medicine
基金 国家自然科学基金(30971266)
  • 相关文献

参考文献2

二级参考文献22

  • 1LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease[J]. N Engl J Med, 2005,352: 1425-1435.
  • 2Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].N Engl J Med, 2004,350: 1495-1504.
  • 3Gylling H, Miettinen TA. Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients [ J ]. Atherosclerosis, 2002,160 : 477 -481.
  • 4Armitage J. The safety of statins in clinical practice [J]. Lancet, 2007,370 : 1781-1790.
  • 5Ballantyne CM, Houri J, Notarbartolo A, et al. Effect of Ezetimibe coadministered with Atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial[J]. Circulation, 2003,107:2409-2415.
  • 6Howard G, Sharrett AR, Heiss G, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound [J]. Stroke, 1993,24: 1297- 1304.
  • 7Herper M. More questions about Vytorin panel. Forbes, March 25, 2008. Available at www.forbes.com.
  • 8Trip MD, van Wissen S, Smilde TJ, et al. Effect of Atorvastatin (80 mg) and Simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia [J]. Am J Cardiol, 2003,91 : 604-606.
  • 9CASHMERE: Pfizer PhRMA Web Synopsis Protocol, A2581051, 29 October 2007 Final Report.
  • 10Drazen JM, Jarcho JA, Morrissey S, et al. Cholesterol lowering and Ezetimibe [J]. N Engl J Med, 2008,358:1507- 1508.

共引文献3

同被引文献74

  • 1Rizzo M,Battista Rini G. Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia[J]. Arch Med Sci ,2011,7( 1 ) :5-7.
  • 2Izadi N, Malek M, Aminian O. Medical risk factors of diabetes mellitus among professional drivers [ J ], Journal of Diabetes and Metabolic Disorders,2013,12( 1 ) :23.
  • 3Qazi MU, Malik S. Diabetes and Cardiovascular Disease:Orig- inal Insights from the Framingham Heart Study [J]. Global Heart,2013,8( 1 ) :43-48.
  • 4Carvalho PM, Silva NJ, Dias PG. Glycogen Storage Disease type i a-a secondary cause for hyperlipidemia: report of five ca- ses [J]. Journal of Diabetes and Metabolic Disorders,2013,12 (1) :25.
  • 5Polymeris A, Karoutsou E, Michalakis K. The impact of bariat- ric surgery procedures on type 2 diabetes, hyperlipidemia and hypertension [J]. Hellenic J Cardio, 2013,54 ( 3 ) : 212 -217.
  • 6Willard-Grace R,Devore D ,Chert EH. The effectiveness of medi- cal assistant health coaching for low-income patients with uncon- trolled diabetes, hypertension, andhyperlipidemia: protocol for a randomized controlled trial and baseline characteristics of the study population [ J]. BMC Family Practice,2013,14( 1 ) :27.
  • 7Lin CF, Gau CS, Wu FL, et al. Impact of ezetimibe coadmin- istered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective co- hort study in Taiwan[ J]. Clin Ther,2011,33(9) :1120-1131.
  • 8Hiramitsu S, Ishiguro Y, Matsuyama H, et al. The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia [J]. J Athero- scler Thromb,2010,17 ( 1 ) : 106-114.
  • 9Goldberg AC,Hopkins PN,Toth PP, et al.Familial hypercholesterolemia:screening, diagnosis and management of pediatric and adult patients:clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia[J].Clin Lipidol,2011,5(3suppl):S 1-8.
  • 10Sjouke B,Kusters DM,Kastelein JJ,et al.Familial hypercholesterolemia:present and future management[J]. Curr Cardiol Rep,2011,13:527-536.

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部